Written by: Deepa Sarkar
The Union Budget 2024 is set to offer significant relief to cancer patients. It has proposed to exempt customs duty on 3 essential cancer drugs with an aim to make treatment more affordable and accessible.
Photo Credit: Shutterstock
Let's delve into the details of this proposal and its expected impact.
Photo Credit: Shutterstock
Cancer treatment expenses are mostly high, but the customs duty exemption will lower the cost of essential drugs like Trastuzumab deruxtecan, Osimertinib, & Durvalumab by 15-20%, easing the financial burden on patients and their families.
Photo Credit: Shutterstock
People suffering from: – HER2-positive breast cancer. (Trastuzumab Deruxtecan). -Non-small cell lung cancer(Osimertinib) – Lung, Liver & Bladder cancer (Durvalumab)
Photo Credit: Shutterstock
Most medical professionals & healthcare experts have welcomed the price reduction, highlighting its potential to improve treatment adherence and outcomes for cancer patients across India.
Photo Credit: Shutterstock
This post is based on the Union Budget 2024 as of July 23. Customs duty changes are not yet active, and no implementation timeline is provided. Please avoid making purchase decisions based on this information.
Photo Credit: Shutterstock